Nuvation Bio Inc.
HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
Last updated:
Abstract:
Novel bromodomain and extraterminal domain (BET) inhibitors and to therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.
Status:
Application
Type:
Utility
Filling date:
1 Jul 2020
Issue date:
7 Jan 2021